AI Designs Reprogramming Drugs, Boosting Efficiency 3x
jacobkimmel · x · 2026-07-11
This update discusses how advanced AI systems are being used for the virtual design of "cellular reprogramming drugs" prior to physical lab experiments.
The core breakthrough: models previously trained on only a single cell type or lineage achieved cross-lineage generalization this summer. Consequently, data learned from one project can directly benefit others, resulting in a >3x improvement in sample efficiency and reducing the number of real experiments needed to launch new projects.
They also shared two experimental updates:
- In a newly launched vascular endothelial repair project, the team quickly set up an assay for age-related functional damage and identified 5 payloads that make older endothelial cells genetically resemble younger cells while improving regenerative function.
- In a metabolic recovery project, candidate drugs accelerated recovery after alcohol consumption in aged animal models, with this enhanced resilience persisting beyond the initial dosage.
More from Companies & People
- Lumara AI Film Festival Comes to NYC Oct 26, Top AI Filmmakers to Compete — 0xAllen_ · 2026-09-11
- X drama: Anthropic researchers accused of spying on academic customers and racing them to results — basedjensen · 2026-09-11
- Investor argues Palantir-Nvidia partnership should slash Anthropic's IPO valuation — pdamodaran · 2026-09-11
- PyTorch Day Korea 2026 launches first offline conf, CFP closes Sept 13 — PyTorch · 2026-09-11
- Class action accuses Anthropic of overselling Claude subscriptions with deceptive usage multipliers — The Decoder · 2026-09-11
- AI post-training and evals jobs pay up to $850K, with median offers at $210K–$325K — FinanceYF5 · 2026-09-11